Plasma miR-15b-5p, miR-338-5p, and miR-764 as biomarkers for hepatocellular carcinoma

Medical Science Monitor

Volumn 21, Issue , 2015, Pages 1864-1871

  Chen, Yi ^a   Chen, Jin ^a   Liu, Yizhao ^a   Li, Shiliang ^a   Huang, Ping ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Circulating; Liver neoplasms; MicroRNAs; Neoplastic cells

Indexed keywords

HSA MICRORNA 101; HSA MICRORNA 1201; HSA MICRORNA 1204; HSA MICRORNA 122; HSA MICRORNA 1254; HSA MICRORNA 1260; HSA MICRORNA 130A; HSA MICRORNA 185; HSA MICRORNA 186; HSA MICRORNA 19B; HSA MICRORNA 222; HSA MICRORNA 26B; HSA MICRORNA 33B; HSA MICRORNA 452; HSA MICRORNA 602; HSA MICRORNA 886 3P; MICRORNA; MICRORNA 15B 5P; MICRORNA 25; MICRORNA 338 5P; MICRORNA 764; UNCLASSIFIED DRUG; TUMOR MARKER;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DNA MICROARRAY; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SENSITIVITY AND SPECIFICITY; UPREGULATION; VALIDATION PROCESS; BLOOD; CARCINOMA, HEPATOCELLULAR; CASE CONTROL STUDY; FEMALE; GENE EXPRESSION PROFILING; GENETICS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; VALIDATION STUDY;

BIOMARKERS, TUMOR; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD;

EID: 84933518372     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.893082     Document Type: Article

References (28)

1. Lozano R, Naghavi M, Foreman K et al: Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 2012; 380(9859): 2095-128
2. Qi J, Wang J, Katayama H et al: Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma. Neoplasma, 2013; 60(2): 135-42
3. de Martel C, Ferlay J, Franceschi S et al: Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol, 2012; 13(6): 607-15
4. Zhou J, Yu L, Gao X et al: Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. Clinical Oncology, 2011; 29(36): 4781-88
5. Liu AM, Yao TJ, Wang W et al: Circulating miR-15b and miR-130b in serum as potential markers for detecting. hepatocellular carcinoma: a retrospective cohort study. BMJ Open, 2012; 2(2): e000825
6. Zhu Z, Zhang X, Wang G et al: Role of MicroRNAs in Hepatocellular Carcinoma. Hepat Mon, 2014; 14(8): e18672
7. Shang C, Lu YM, Meng LR: MicroRNA-125b down-regulation mediates endometrial cancer invasion by targeting ERBB2. Med Sci Monit, 2012; 18(4): BR149-55
8. Fang Y, Fang D, Hu J: MicroRNA and its roles in esophageal cancer. Med Sci Monit, 2012; 18(3): RA22-30
9. Wang Z, Cai Q, Jiang Z et al: Prognostic Role of MicroRNA-21 in Gastric Cancer: A Meta-Analysis. Med Sci Monit, 2014; 20: 1668-74
10. Wang X, Lu X, Fang Y et al: Association between miR34b/c polymorphism rs4938723 and cancer risk: A meta-analysis of 11 studies including 6169 cases and 6337 controls. Med Sci Monit, 2014; 20: 1977-82
11. Hayes J, Peruzzi PP, Lawler S: MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol Med, 2014: pii: S1471-4914(14)00101-4
12. Chen X, Ba Y, Ma L et al: Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res, 2008; 18(10): 997-1006
13. Tomimaru Y, Eguchi H, Nagano H et al: Circulating microRNA-21 as a novel biomarker for: hepatocellular carcinoma. J Hepatol, 2012; 56(1): 167-75
14. Qi P, Cheng SQ, Wang H et al: Serum MicroRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. PLoS One, 2011; 6(12): e28486
15. Karakatsanis A, Papaconstantinou I, Gazouli M et al: Expression of microR-NAs, miR-21, miR-31,miR-122, miR-145, miR-146a, miR-200c,miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance. Mol Carcinog, 2013; 52(4): 297-303
16. Li L, Guo Z, Wang J et al: Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening. Dig Dis Sci, 2012; 57(11): 2910-16
17. Abdalla MA, Haj-Ahmad Y: Promising Candidate Urinary MicroRNA Biomarkers for the Early Detection of Hepatocellular Carcinoma amongHigh-Risk Hepatitis C Virus Egyptian Patients. J Cancer, 2012; 3: 19-31
18. Li J, Wang Y, Yu W et al: Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance. Biochem Biophys Res Commun, 2011; 406(1): 70-73
19. Gui J, Tian Y, Wen X et al: Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies. Clin Sci (Lond), 2011; 120(5): 183-93
20. Luo J, Chen M, Huang H et al: Circulating microRNA-122a as a diagnostic marker for hepatocellular carcinoma. Onco Targets Ther, 2013; 6: 577-83
21. Dai X, Zhang W, Zhang H et al: Modulation of HBV replication by microR-NA-15b through targeting hepatocyte nuclear factor 1a. Nucleic Acids Res, 2014; 42(10): 6578-90
22. Wu CS, Yen CJ, Chou RH et al: Downregulation of microRNA-15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltrans-ferase 2-induced Globo H expression. Int J Cancer, 2014; 134(7): 1638-47
23. Cantara S, Pilli T, Sebastiani G et al: Circulating miRNA95 and miRNA190 are sensitive markers for the differential diagnosis of thyroid nodules in a Caucasian population. J Clin Endocrinol Metab, 2014; 24: jc20141923
24. Shen J, Hu Q, Schrauder M et al: Circulating miR-148b and miR-133a as biomarkers for breast cancer detection. Oncotarget, 2014; 5(14): 5284-94
25. Syring I, Bartels J, Holdenrieder S et al: Circulating serum microRNA (miR-367-3p, miR-371a-3p, miR-372-3p, miR-373-3p) as biomarkers for patients with testicular germ cell cancers. J Urol, 2014; pii: S0022-5347(14)03957-3
26. Slater EP, Strauch K, Rospleszcz S et al: MicroRNA-196a and -196b as potential biomarkers for the early detection of familial pancreatic cancer. Transl Oncol, 2014; pii: S1936-5233(14)00062-X
27. Ulivi P, Zoli W: miRNAs as non-invasive biomarkers for lung cancer diagnosis. Molecules, 2014; 19(6): 8220-37
28. Tsujiura M, Komatsu S, Ichikawa D et al: Circulating miR-18a in plasma contributes to cancer detection and monitoring in patients with gastric cancer. Gastric Cancer, 2014 [Epub ahead of print]